New Cancer Drug Benefits Lung Cancer Patients

Novel cancer drug durvalumab was found to significantly decrease the recurrence of lung cancer both in the chest area and in distant sites outside the chest, stated new significantly decreased the recurrence of lung cancer both in the chest area and in distant sites outside the chest. A new analysis of survival data for the randomized, phase III PACIFIC trial finds adding the immunotherapy cancer drug durvalumab to radiation and chemotherapy significantly decreased the recurrence of lung cancer ...